Review
Open access
Oct 2026
Type 1 diabetes mellitus during immune checkpoint inhibitor therapy in cancer patients
The development of immune checkpoint inhibitors (ICIs) has led to significant changes in the treatment strategies for malignant tumors. Results from numerous randomized trials of this class of drugs, alongside their widespread adoption in clinical practice, have demonstrated superior therapeutic efficacy in patients wi...
R. Orlova, I. V. Gerk, I. Itkin et al.
· Clinical Case in Oncology · 0 citations